首页 | 本学科首页   官方微博 | 高级检索  
     

终末期糖尿病肾病的血液透析与腹膜透析的比较研究
引用本文:汤梦娟 李岩 肖蕊 赵延 赵静 詹科. 终末期糖尿病肾病的血液透析与腹膜透析的比较研究[J]. 现代生物医学进展, 2015, 15(20): 3886-3888
作者姓名:汤梦娟 李岩 肖蕊 赵延 赵静 詹科
作者单位:湖南旺旺医院肾内科
基金项目:卫生部医药卫生科技发展研究中心课题基金资助项目(W2013GJ09)
摘    要:目的:探讨终末期糖尿病肾病患者接受不同透析方法的临床疗效。方法:40例终末期糖尿病肾病患者,按照透析方式分为血液透析和腹膜透析组,回顾性分析其临床资料。结果:血液透析与腹膜透析在血压控制,血糖,白蛋白、血总蛋白,肌酐、尿素氮水平,甘油三酯以及出血发生率等各项指标有其各自的优劣性,但是均可使患者获益,提高生存率,生存率比较无统计学差异。结论:及时、恰当的选择肾脏替代治疗,并在治疗过程中及时调整,甚或更换方案对终末期糖尿病肾病患者是有益的。

关 键 词:糖尿病肾病;血液透析;腹膜透析

Comparative Study of Hemodialysis and PeritonealDialysis in Treating Diabetic Nephropathy in End-Stage
Abstract:Objective:To investigate the clinic effect of hemodialysis and peritoneal dialysis on diabetic nephropathy patients inend-stage.Methods:Forty patients with diabetic nephropathy in end-stage were divided into two groups according to the way receivingdifferent treatments. Patiens in the CAPD group received continuous ambulatory peritoneal dialysis and patients in HD group receivedhemodialysis Their clinical data were analyzed contrastively.Results:CAPD and HD each had its own advantages in the blood pressurecontrol, blood glucose, albumin, serum total protein, creatinine, urea nitrogen, triglyceride and the bleeding rate and other indicators, butboth can make patients benefit and improve survival rate. There were no obvious differences in survival rate between the two groups.Conclusion:The proper choice and the interchange of the ways of renal replacement treatment were useful to improve the life quality ofthe patients with diabetic nephropathy in end-stage.
Keywords:Diabetic Nephropathy   Hemodialysis   Peritoneal Dialysis
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号